Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
JM Smith Corporation v. AstraZeneca Pharmaceuticals L P et al
Case Number:
1:19-cv-07233
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Alston & Bird
- Berger Montague
- Davis Malm & D’Agostine
- Faruqi & Faruqi
- Garwin Gerstein
- Hangley Aronchick
- O'Melveny & Myers
- Vinson & Elkins
- Williams & Connolly
- Wilson Sonsini
Companies
- Albertsons Cos. Inc.
- AstraZeneca PLC
- CVS Health Corp.
- Hy-Vee
- J.M. Smith Corp.
- Rite Aid Corp.
- The Kroger Co.
Sectors & Industries:
-
November 01, 2019
Seroquel XR Suits Belong In Delaware, AstraZeneca Says
AstraZeneca has urged a New York federal judge to transfer consolidated proposed class actions accusing the company of paying off generic-drug makers to protect its brand antipsychotic drug Seroquel XR, arguing the cases belong in Delaware if they are not tossed outright.
-
August 02, 2019
AstraZeneca Hit With Pay-For-Delay Suit Over Seroquel XR
Drug distributor J.M. Smith Corp. slapped AstraZeneca with an antitrust lawsuit in New York federal court on Friday claiming the pharmaceutical giant paid off a pair of generic-drug makers to stave off rivals to its brand anti-psychotic drug.